- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02238886
Radical Cystectomy, Nutrition and Convalescence
RADICAL CYSTECTOMY, NUTRITION AND CONVALESCENCE: CAN GOAL-DIRECTED POSTOPERATIVE NUTRITIONAL THERAPY REDUCE THE CONVALESCENCE PERIOD FOR PATIENTS UNDERGOING RADICAL CYSTECTOMY (RC)?
The purpose of this study is to determine whether a goal directed nutritional intervention can reduce the convalescence period for patients undergoing radical cystectomy (RC).
The aim is to examine the effect on quality of life of a standard nutritional strategy of resting the bowel till clear signs of bowel recovery and feeding orally after bowel recovery versus a goal-directed nutritional intervention combining oral intake and parenteral nutrition, in patients undergoing RC.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study is a randomized controlled trial. Inclusion criteria: Bladder cancer, ability to give an informed consent. Exclusion criteria: Previous radiation therapy at the pelvic area, ureterocutaneostomy or robot-assisted surgery. The intervention aims to secure that 75% of the patient's total energy and protein needs are met during hospitalization.
Primary outcome: Quality of Life, using the EORTC QLQ-C30 and BLM30 questionnaire. Secondary outcomes: Body-weight, Hand Grip strength, biochemical measures, length of hospital stay, time to bowel recovery. The follow-up period is 12 weeks. Statistical analysis is performed in collaboration with a statistician.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Copenhagen, Denmark, 2100
- Dep. of Urology. University Hospital Rigshospitalet, Copenhagen Denmark
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Bladder cancer
- Ability to give an informed consent
Exclusion Criteria:
- Previous radiation therapy at the pelvic area
- Ureterocutaneostomy
- Robot-assisted surgery
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Parenteral nutrition
Patients receives a goal-directed nutritional intervention combining oral intake and parenteral nutrition
|
|
No Intervention: Standard treatment
patients receives a standard nutritional strategy of resting the bowel till clear signs of bowel recovery and feeding orally after bowel recovery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Health related quality of life (HRQoL) using the EORTC QLQ-C30 and BLM30 (one combined questionnaire)
Time Frame: meassured pre-operatively + 6 and 12 weeks following surgery
|
Change from baseline HRQoL at 6 and 12 weeks following surgery
|
meassured pre-operatively + 6 and 12 weeks following surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body weight
Time Frame: preoperatively, 6 and 12 weeks postop
|
Change from baseline weight at 6 and 12 weeks following the date of surgery
|
preoperatively, 6 and 12 weeks postop
|
hand grip strength
Time Frame: pre-operatively, 6 days and 6 weeks postop
|
Change from baseline hand grip strength at 6 days and 6 weeks following the date of surgery
|
pre-operatively, 6 days and 6 weeks postop
|
length of hospital stay
Time Frame: 12 week follow-up
|
12 week follow-up
|
|
Time to bowel recovery
Time Frame: 12 week follow-up
|
12 week follow-up
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-2-2011-114
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urinary Bladder Neoplasms
-
Peking University First HospitalRecruitingUrinary Bladder Cancer | Bladder Cancer | Bladder Neoplasms | Bladder Tumors | Neoplasms, BladderChina
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Bristol-Myers SquibbRecruitingUrinary Bladder Cancer | Invasive Bladder CancerNetherlands
-
GlaxoSmithKlineCompletedNeoplasms, Urinary BladderBelgium
-
Memorial Sloan Kettering Cancer CenterPfizerCompletedBladder Cancer | Urinary BladderUnited States
-
Mansoura UniversityCompletedBladder Cancer | Bladder Disease | Bladder Neoplasm | Micro-RNAEgypt
-
Medical University of ViennaUniversity of Turin, ItalyRecruitingT1 Urinary Bladder CancerAustria
-
Zhujiang HospitalRecruiting
-
Chinese University of Hong KongUnknownUrinary Bladder TumorHong Kong
-
Ziv HospitalAzrieli Faculty of medicine, Bar Ilan University, Safed, ILNot yet recruitingBladder Neoplasm
-
Ziv HospitalNot yet recruitingBladder Neoplasm
Clinical Trials on Parenteral nutrition. SMOFKABIVEN infusion in central vene. Fresenius Kabi
-
General University Hospital, PragueCharles University, Czech Republic; Ministry of Health, Czech RepublicCompletedParenteral NutritionCzechia
-
Radboud University Medical CenterCompleted
-
Wei ZhouUnknownLiver Tumor | Gastric Tumor | Pancreatic TumorChina
-
Centro Hospitalar de Lisboa CentralTerminatedIntrahepatic, Cholestasis
-
Ulrik GrevstadCompletedKnee Replacement ArthroplastyDenmark
-
Klinikum LudwigshafenCompletedInflammatory Response | Hepatic FunctionGermany
-
St. Olavs HospitalNovo Nordisk A/S; Norwegian University of Science and Technology; Norwegian Foundation... and other collaboratorsCompleted
-
Universidad del DesarrolloCompleted
-
St. Petersburg State Pavlov Medical UniversityCompleted